Vetal

Vetal is a prominent Turkish biotechnology and pharmaceutical company primarily focused on animal health and vaccine production. Established in 1991, the company maintains large-scale manufacturing facilities in Adıyaman that are compliant with Good Manufacturing Practices (GMP). While its core business involves veterinary vaccines and medicines, Vetal gained significant attention for its role in human health during the COVID-19 pandemic, where it partnered with academic researchers to develop a virus-like particle (VLP) vaccine. The company's portfolio includes a diverse range of biological products and pharmaceuticals exported to numerous countries. Its infrastructure includes advanced R&D laboratories and large-scale production units for both biological and chemical products.